当前位置: X-MOL 学术Epilepsia › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Efficacy and safety of Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: A real‐world study
Epilepsia ( IF 6.6 ) Pub Date : 2020-09-18 , DOI: 10.1111/epi.16690
Nicola Specchio 1 , Nicola Pietrafusa 1 , Viola Doccini 2 , Marina Trivisano 1 , Francesca Darra 3 , Francesca Ragona 4 , Alberto Cossu 3 , Silvia Spolverato 3 , Domenica Battaglia 5 , Michela Quintiliani 5 , Maria Luigia Gambardella 5 , Anna Rosati 2 , Davide Mei 2 , Tiziana Granata 4 , Bernardo Dalla Bernardina 3 , Federico Vigevano 6 , Renzo Guerrini 3
Affiliation  

Dravet syndrome (DS) is a drug‐resistant, infantile onset epilepsy syndrome with multiple seizure types and developmental delay. In recently published randomized controlled trials, fenfluramine (FFA) proved to be safe and effective in DS.

中文翻译:

盐酸芬氟拉明治疗 Dravet 综合征癫痫发作的有效性和安全性:一项真实世界的研究

Dravet 综合征 (DS) 是一种具有多种癫痫发作类型和发育迟缓的耐药性婴儿型癫痫综合征。在最近发表的随机对照试验中,芬氟拉明 (FFA) 被证明对 DS 是安全有效的。
更新日期:2020-09-18
down
wechat
bug